top of page
IPSC (Induced Differentiated Stem Cells)
LP Cell Korea is an IPSC commercialization company equipped with technology, equipment, and a production platform.
We possess the capability to lead major deals in the domestic and international treatment markets.
IPSC (Induced Differentiated Stem Cells)
- IPSC (Induced Pluripotent Stem Cell) is based on 'reprogramming' technology that reverts already differentiated somatic cells back to a stem cell state.
- Direct Conversion: Converting a single differentiated cell into a completely different cell lineage for use in cell replacement therapy for damaged tissues or organs.
This technology is a core technology of regenerative medicine, including patient-specific cell therapy, treatment of intractable diseases, and reversal of aging.
Current Status of LP Cell Korea's IPSC Technology
- LP Cell Korea currently possesses IPSC technology at a level suitable for clinical application.
- It is possible to establish a mass production system through IPSC module facilities.
- The importance and economic benefits of automated equipment have been proven through comparative analysis and verification, serving as a key competitive advantage for maximizing sales and securing market dominance.
Innovative IPSC Production Solutions
01
Automation and optimization of the IPSC generation process
- Combining advanced biotechnology with robotics + fluid dynamics-based systems
- Simultaneous mass production of IPSC derived from multiple donors is possible within a single cleanroom
- In particular, mass production of personalized IPSC is virtually impossible with existing technology.
02
Key Features of Next-Generation Manufacturing Platforms
- Reduced production time and minimized errors through a fully automated manufacturing process
- Production of clinical-grade IPSC possible in GMP-certified facilities
- Customers can select a customized IPSC line based on differentiation trends, securing clinical efficiency, cost reduction, and research speed.
03
Technological exclusivity and scalability
- IPSC automation equipment and processes are based on a proprietary platform
B2B services available in various fields such as regenerative medicine, new drug development, and clinical research.
Cardiac muscle cells
IPSC
⇣
Can differentiate into various cell types
liver cells
immune cells
(T/NK cells)
Mesenchymal stem cells
(MSC)
nerve cells
(Neurons and glial cells)
Automated high-efficiency division system
- Mass differentiation of IPSCs derived from multiple donors in the same space
- Ensuring process efficiency and quality consistency
- In addition to therapeutic cells, we can supply research-grade IPSC products and services.
Technological differentiation
With LP Cell Korea's differentiated technology
We provide highly satisfactory treatments and products.
3D volumetric culture and
Membrane Exosome
Overwhelming practical technical skills
Differentiated ingredients
bottom of page